AU2703695A - Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine - Google Patents

Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine

Info

Publication number
AU2703695A
AU2703695A AU27036/95A AU2703695A AU2703695A AU 2703695 A AU2703695 A AU 2703695A AU 27036/95 A AU27036/95 A AU 27036/95A AU 2703695 A AU2703695 A AU 2703695A AU 2703695 A AU2703695 A AU 2703695A
Authority
AU
Australia
Prior art keywords
nicotine
xanthine
caffeine
treatment
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27036/95A
Inventor
Satyanarayana Majeti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU2703695A publication Critical patent/AU2703695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU27036/95A 1994-06-23 1995-06-09 Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine Abandoned AU2703695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US264262 1988-10-28
US26426294A 1994-06-23 1994-06-23
PCT/US1995/007425 WO1996000071A1 (en) 1994-06-23 1995-06-09 Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine

Publications (1)

Publication Number Publication Date
AU2703695A true AU2703695A (en) 1996-01-19

Family

ID=23005260

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27036/95A Abandoned AU2703695A (en) 1994-06-23 1995-06-09 Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine

Country Status (6)

Country Link
AU (1) AU2703695A (en)
IL (1) IL114129A0 (en)
MA (1) MA23588A1 (en)
PE (1) PE33396A1 (en)
WO (1) WO1996000071A1 (en)
ZA (1) ZA955032B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7078016B2 (en) 2001-11-21 2006-07-18 Alexza Pharmaceuticals, Inc. Delivery of caffeine through an inhalation route
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
CA2526475A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US20110053988A1 (en) * 2009-08-29 2011-03-03 Jorge Alberto Cassara Low-dose, non-irritating nicotine nasal composition to reduce the desire to smoke
DE102011114094A1 (en) * 2011-09-21 2013-03-21 F. Holzer Gmbh Stimulating and invigorating nasal spray and nose drops
CA3014725C (en) 2016-04-12 2020-09-22 Arturo Solis Herrera Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists
EP3781191A4 (en) * 2018-04-16 2022-01-19 Barista Mist Pty Ltd Caffeine compositions and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (en) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg DEVICE FOR THE DEWNING OF EATING, DRINKING, SMOKING AND / OR ADDICTIVE Habits
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency

Also Published As

Publication number Publication date
MA23588A1 (en) 1995-12-31
IL114129A0 (en) 1995-10-31
PE33396A1 (en) 1996-08-19
WO1996000071A1 (en) 1996-01-04
ZA955032B (en) 1996-03-11

Similar Documents

Publication Publication Date Title
AU2703795A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
AU2770895A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with an oral composition containing nicotine and caffeine or xanthine
CA2127253A1 (en) Composition to help stop smoking
EP0296236A4 (en) Nasal delivery of caffeine.
AU1992592A (en) Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
AU2703695A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine
AU2569988A (en) Process and apparatus for the semicontinuous extraction of nicotine from tobacco
NZ254550A (en) Use of nitrogen-substituted pyrimidines to prepare medicaments useful for treatment or prevention of diabetic complications
EP0725659A4 (en) Percutaneous port catheter and method of use
HK96696A (en) Filter for tobacco smoking
AU2207088A (en) Cigarette filter rods and cigarettes incorporating such filter rods
AU2702795A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
IL117970A (en) Pharmaceutical compositions containing olanzapine for treating nicotine withdrawal
AU4476089A (en) Use of azepinone derivatives for the treatment of respiratory tract disorders
ZA886249B (en) Use of a compound for the treatment of sleep disorders and depression
AU8096094A (en) Use of nicotine substitutes for the treatment of nicotine withdrawal
AU3879789A (en) Use of benzo(g)quinolines in treatment of nicotine addiction
WO1995010950A3 (en) Filter cigarette with filter at both ends
AU2446895A (en) Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
GB9410482D0 (en) Tobacco smokers' mouthpiece
HUP9801236A3 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
AU2294192A (en) Transdermal nicotine absorption dosage unit and process
AU4096689A (en) The use of lactam derivatives in the treatment of addiction
AUPO292896A0 (en) Absorption and delivery of nasal nicotine